Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -21,651 | -26,296 | -26,387 | -11,690 | -587 |
| Depreciation Amortization | 1,017 | 866 | 380 | 70 | 61 |
| Accounts receivable | 64 | 16 | -211 | 24 | -99 |
| Other Working Capital | 52 | -65 | 1,387 | -139 | 58 |
| Other Operating Activity | 3,428 | 3,540 | 10,062 | 8,514 | 99 |
| Operating Cash Flow | $-17,090 | $-21,939 | $-14,770 | $-3,220 | $-469 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -82 | -1,199 | -659 | -17 | -10 |
| Net Acquisitions | 33 | N/A | N/A | 1,220 | N/A |
| Purchase Sale Intangibles | -150 | -700 | N/A | N/A | N/A |
| Other Investing Activity | -150 | -700 | 0 | 0 | 0 |
| Investing Cash Flow | $-199 | $-1,899 | $-659 | $1,203 | $-10 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2 | 25 |
| Debt Issued | 4,310 | 10,120 | N/A | 8 | 11 |
| Debt Repayment | -1,180 | -1,100 | N/A | N/A | N/A |
| Common Stock Issued | 13,765 | 6,393 | 24,248 | 10,425 | N/A |
| Other Financing Activity | -295 | -1,186 | -305 | 175 | 360 |
| Financing Cash Flow | $16,600 | $14,227 | $23,943 | $10,611 | $397 |
| Exchange Rate Effect | -146 | -460 | -101 | 12 | 1 |
| Beginning Cash Position | 7,071 | 17,142 | 8,728 | 123 | 204 |
| End Cash Position | 6,236 | 7,071 | 17,142 | 8,728 | 123 |
| Net Cash Flow | $-835 | $-10,071 | $8,414 | $8,605 | $-82 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,090 | -21,939 | -14,770 | -3,220 | -469 |
| Capital Expenditure | -105 | -1,199 | -659 | -17 | -10 |
| Free Cash Flow | -17,195 | -23,138 | -15,428 | -3,237 | -478 |